(0.20%) 5 142.00 points
(0.20%) 38 518 points
(0.29%) 17 898 points
(-0.97%) $83.04
(1.56%) $1.953
(-0.29%) $2 340.30
(-0.22%) $27.48
(0.28%) $924.70
(-0.16%) $0.933
(-0.09%) $11.02
(-0.20%) $0.799
(0.81%) $92.62
Quarter results today
(bmo 2024-04-29)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies...
Stats | |
---|---|
Šios dienos apimtis | 63 500.00 |
Vidutinė apimtis | 78 645.00 |
Rinkos kapitalizacija | 42.86B |
EPS | ¥0 ( 2024-04-25 ) |
Last Dividend | ¥12.50 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 11.25 |
ATR14 | ¥1.537 (0.10%) |
Tūris Koreliacija
Nihon Chouzai Co.,Ltd. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Nihon Chouzai Co.,Ltd. Koreliacija - Valiuta/Žaliavos
Nihon Chouzai Co.,Ltd. Finansinės ataskaitos
Annual | 2022 |
Pajamos: | ¥313.32B |
Bruto pelnas: | ¥53.64B (17.12 %) |
EPS: | ¥148.90 |
FY | 2022 |
Pajamos: | ¥313.32B |
Bruto pelnas: | ¥53.64B (17.12 %) |
EPS: | ¥148.90 |
FY | 2022 |
Pajamos: | ¥299.39B |
Bruto pelnas: | ¥52.42B (17.51 %) |
EPS: | ¥123.56 |
FY | 2021 |
Pajamos: | ¥278.95B |
Bruto pelnas: | ¥49.37B (17.70 %) |
EPS: | ¥118.01 |
Financial Reports:
No articles found.
Nihon Chouzai Co.,Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥12.50 (N/A) |
¥0 (N/A) |
¥12.50 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥5.00 | 2007-03-27 |
Last Dividend | ¥12.50 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 30 | -- |
Total Paid Out | ¥300.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.93 | -- |
Div. Sustainability Score | 8.01 | |
Div.Growth Potential Score | 2.88 | |
Div. Directional Score | 5.45 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8011.T | Ex Dividend Junior | 2024-02-28 | Sporadic | 0 | 0.00% | |
7250.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6486.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5703.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4523.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3681.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2975.T | Ex Dividend Knight | 2023-11-29 | Semi-Annually | 0 | 0.00% | |
1827.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9832.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8897.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0118 | 1.500 | 9.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0203 | 1.200 | 9.32 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0683 | 1.500 | -0.352 | -0.528 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.066 | 0.800 | 9.67 | 7.74 | [1 - 3] |
quickRatioTTM | 0.484 | 0.800 | -1.860 | -1.488 | [0.8 - 2.5] |
cashRatioTTM | 0.204 | 1.500 | 9.98 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.269 | -1.500 | 5.52 | -8.27 | [0 - 0.6] |
interestCoverageTTM | 25.33 | 1.000 | 1.731 | 1.731 | [3 - 30] |
operatingCashFlowPerShareTTM | 591.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 591.56 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.879 | -1.500 | 6.49 | -9.73 | [0 - 2.5] |
grossProfitMarginTTM | 0.167 | 1.000 | -0.552 | -0.552 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0248 | 1.000 | -1.503 | -1.503 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.338 | 1.000 | 9.23 | 9.23 | [0.2 - 2] |
assetTurnoverTTM | 1.722 | 0.800 | 1.857 | 1.485 | [0.5 - 2] |
Total Score | 8.01 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.26 | 1.000 | 8.96 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0683 | 2.50 | -0.226 | -0.528 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 591.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.687 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 591.56 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.341 | 1.500 | -5.61 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0529 | 1.000 | -1.178 | 0 | [0.1 - 0.5] |
Total Score | 2.88 |
Nihon Chouzai Co.,Ltd.
Nihon Chouzai Co., Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. The company also manufactures and sells generic drugs to medical institutions and other pharmacies. In addition, it offers temporary staffing services for pharmacist; and employment services for physicians and registered sales personnel, and other healthcare professionals. Further, the company provides studies and research services for pharmaceutical companies and organizations; information and consulting services for industries associated with pharmaceuticals and healthcare; and other services. As of March 31, 2022, it had 697 stores. The company was incorporated in 1980 and is headquartered in Tokyo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.